Sana Biotechnology, Inc.
NASDAQ:SANA
1.76 (USD) • At close April 28, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 30.865 | 27.731 | 17.914 | 10.171 | 3.921 | 0.001 |
| Brutowinst
| 0 | -30.865 | -27.731 | -17.914 | -10.171 | -3.921 | -0.001 |
| Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 217.564 | 221.641 | 201.003 | 306.499 | 257.879 | 119.375 | 4.014 |
| Algemene en administratieve kosten
| 64.04 | 73.299 | 71.561 | 50.41 | 28.27 | 21.777 | 8.412 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | -4.206 |
| Verkoop-, algemene en administratieve kosten
| 64.04 | 73.299 | 71.561 | 50.41 | 28.27 | 21.777 | 4.206 |
| Overige kosten
| 0 | 0 | -0.674 | 0.305 | 0.097 | -0.029 | 0 |
| Bedrijfskosten
| 281.604 | 294.94 | 272.564 | 356.909 | 286.149 | 141.152 | 8.22 |
| Bedrijfsresultaat
| -272.723 | -326.9 | -272.564 | -356.909 | -286.149 | -141.152 | -8.221 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 5.964 | 43.645 | 3.088 | 0.981 | 0.844 | 2.827 | -5.026 |
| Inkomen voor belasting
| -266.759 | -283.255 | -269.476 | -355.928 | -285.305 | -138.325 | -13.247 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0 | -3.088 | -11.746 | -6.668 | -7.547 | 0 |
| Nettowinst
| -266.759 | -283.255 | -266.388 | -344.182 | -278.637 | -130.778 | -13.247 |
| Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -1.16 | -1.46 | -1.41 | -2.07 | -1.49 | -0.7 | -0.071 |
| Verwaterde WPA
| -1.16 | -1.46 | -1.41 | -2.07 | -1.49 | -0.7 | -0.071 |
| EBITDA
| -272.723 | -252.39 | -256.939 | -356.909 | -287.034 | -138.904 | -13.246 |
| EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |